Clinical Trial Update: Effect of Iron Reduction by Phlebotomy for Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating whether reducing body iron through phlebotomy impacts outcomes in people with Type 2 diabetes mellitus or prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Utah | Conditions: Type 2 Diabetes Mellitus, Prediabetes | NA | Status: COMPLETED